No Data
No Data
Baiyunshan ph (00874) received the "Pharmaceutical Production License" approved and issued by the Guangdong Pharmaceutical Supervision Administration.
Baiyunshan (00874) announced that its wholly-owned subsidiary, Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. (also known as...
Baiyunshan (00874) dropped 25.50%, currently trading at 17.360 yuan, hitting a new 52-week low.
As of 11:43, Baiyunshan (00874) fell 25.50% compared to the previous closing price and is now reported at 17.360 yuan, hitting a 52-week low. The trading volume is 0.926 million shares, with a turnover of 16.0908 million Hong Kong dollars.
Baiyunshan Pharmaceutical's Executive Director Resigns Amid Ongoing Investigation
Hong Kong stocks have changed | Baiyunshan (00874) is now down more than 5%, and the net income attributable to the mother has decreased by 9.31% year-on-year. Former Chairman Li Chuyuan is under investigation.
baiyunshan (00874) fell more than 5%, as of the time of writing, it fell by 5.45%, to 18.38 Hong Kong dollars, with a turnover of 29.2393 million Hong Kong dollars.
Director Zhang Chunbo of Baiyunshan (600332.SH) resigns.
baiyunshan ph (600332.SH) announced that the board of directors of the company received a resignation letter from director Zhang Chun on August 30, 2024...
Full text of the 2024 semi-annual report of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.
No Data